Omalizumab safely manages Chronic spontaneous urticaria during pregnancy Aditi19 Dec 2023 6:00 AM ISTTreating a pregnant patient with chronic spontaneous urticaria (CSU) can be quite challenging. According to recent findings, most CSU treatments for...
Omalizumab may improve outcomes among patients with chronic rhinosinusitis with nasal polyps independent of allergic status Dr Riya Dave9 Dec 2023 11:15 AM ISTA recent analysis sheds light on the efficacy of omalizumab, an immunoglobulin E (IgE) monoclonal antibody, in managing Chronic Rhinosinusitis with...
Elevated marker of IgE-mediated mast cell activation predicts omalizumab response in chronic spontaneous urticaria Medha Baranwal19 Sept 2023 10:15 AM ISTOmalizumab is an anti-IgE monoclonal antibody that is suggested to be an effective treatment in chronic spontaneous urticaria.
Omalizumab may reduce severe Asthma Exacerbations, finds study Dr.Niharika Harsha B29 July 2022 10:00 AM ISTNew Investigation into Asthma condition found that despite the atopic status, Omalizumab was effective in severe asthma. This was published in...
Pros of Switching from omalizumab or mepolizumab to Benralizumab in asthma patients Isra Zaman1 Jun 2022 10:30 AM ISTPatients diagnosed with severe refractory eosinophilic asthma who experience a partial response with omalizumab or mepolizumab could benefit from...
Single dose of omalizumab before pollen season beneficial in seasonal allergic rhinitis: Study Dr. Shravani Dali24 Feb 2022 9:00 AM ISTA dose of omalizumab administered before pollen season improved symptom control and quality of life compared with standard medication among patients...
Ligelizumab and omalizumab effective for treating chronic spontaneous urticaria: JAMA MD Editorial Team28 Sept 2021 6:45 PM ISTThailand: Biologic agents ligelizumab, 72 or 240 mg, and omalizumab, 300 or 600 mg can be recommended as effective treatments for chronic spontaneous...
Ligelizumab more effective than Omalizumab in chronic spontaneous urticaria: Study Medha Baranwal6 May 2021 6:00 PM ISTUSA: Ligelizumab is more effective in reducing chronic spontaneous urticaria (CSU) severity compared with omalizumab, according to findings from a...
Omalizumab reduces exacerbations of severe persistent asthma, Finds study Dr. Nandita Mohan2 May 2021 9:37 PM ISTResearchers have recently found out that adding omalizumab to the treatment of patients with uncontrolled severe persistent asthma reduces the...
Recent expert guidelines on management of chronic utricaria in clinical practise Dr Satabdi Saha18 March 2021 1:45 PM ISTChronic urticaria (CU) is a common disease which represents a considerable burden for many patients. The current urticaria guideline describes the...
Novartis gets CDSCO Committee nod to Xolair to treat rhinosinusitis with nasal polyps Medical Dialogues Team17 March 2021 9:15 AM ISTNew Delhi: Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has granted permission to Novartis...
Omalizumab shows efficacy in asthmatics in the long run: claims study Dr Satabdi Saha17 Dec 2020 10:34 AM ISTAccording to a recent research, Omalizumab therapy has proven to be very effective, with this efficacy sustained after 4 years of treatment....
